Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;17(6):e13830.
doi: 10.1111/cts.13830.

A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data

Affiliations

A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data

Shobana John et al. Clin Transl Sci. 2024 Jun.

Abstract

Computational methods analyze genomic data to identify genetic variants linked to drug responses, thereby guiding personalized medicine. This study analyzed 942 whole-genome sequences from the Electricity Generating Authority of Thailand (EGAT) cohort to establish a population-specific pharmacogenomic database (TPGxD-1) in the Thai population. Sentieon (version 201808.08) implemented the GATK best workflow practice for variant calling. We then annotated variant call format (VCF) files using Golden Helix VarSeq 2.5.0 and employed Stargazer v2.0.2 for star allele analysis. The analysis of 63 very important pharmacogenes (VIPGx) reveals 85,566 variants, including 13,532 novel discoveries. Notably, we identified 464 known PGx variants and 275 clinically relevant novel variants. The phenotypic prediction of 15 VIPGx demonstrated a varied metabolic profile for the Thai population. Genes like CYP2C9 (9%), CYP3A5 (45.2%), CYP2B6 (9.4%), NUDT15 (15%), CYP2D6 (47%) and CYP2C19 (43%) showed a high number of intermediate metabolizers; CYP3A5 (41%), and CYP2C19 (9.9%) showed more poor metabolizers. CYP1A2 (52.7%) and CYP2B6 (7.6%) were found to have a higher number of ultra-metabolizers. The functional prediction of the remaining 10 VIPGx genes reveals a high frequency of decreased functional alleles in SULT1A1 (12%), NAT2 (84%), and G6PD (12%). SLCO1B1 reports 20% poor functional alleles, while PTGIS (42%), SLCO1B1 (4%), and TPMT (5.96%) showed increased functional alleles. This study discovered new variants and alleles in the 63 VIPGx genes among the Thai population, offering insights into advancing clinical pharmacogenomics (PGx). However, further validation is needed using other computational and genotyping methods.

PubMed Disclaimer

Conflict of interest statement

The authors declared no competing interests for this work.

Figures

FIGURE 1
FIGURE 1
Process of calling star alleles and identifying variants. Notes: For CYP2D6, according to the Stargazer v2.0.2, both PGx‐VCF and GDF files were used to analyze the structural variation and VDR was used as a control gene. Abbreviation: BAM, Binary Alignment Map.

Similar articles

Cited by

References

    1. Stratton TP, Olson AW. Personalizing personalized medicine: the confluence of pharmacogenomics, a Person's medication experience and ethics. Pharmacy (Basel, Switzerland). 2023;11(3):101. doi:10.3390/pharmacy11030101 - DOI - PMC - PubMed
    1. Nogueiras‐Álvarez R. Pharmacogenomics in clinical trials: an overview. Front Pharmacol. 2023;14:1247088. doi:10.3389/fphar.2023.1247088 - DOI - PMC - PubMed
    1. Tafazoli A, Guchelaar HJ, Miltyk W, Kretowski AJ, Swen JJ. Applying next‐generation sequencing platforms for pharmacogenomic testing in clinical practice. Front Pharmacol. 2021;12:693453. doi:10.3389/fphar.2021.693453 - DOI - PMC - PubMed
    1. Shugg T, Ly RC, Osei W, et al. Computational pharmacogenotype extraction from clinical next‐generation sequencing. Front Oncol. 2023;13:1199741. doi:10.3389/fonc.2023.1199741 - DOI - PMC - PubMed
    1. Gaedigk A, Boone EC, Scherer SE, et al. CYP2C8, CYP2C9, and CYP2C19 characterization using next‐generation sequencing and haplotype analysis: a GeT‐RM collaborative project. J Mol Diagn. 2022;24(4):337‐350. doi:10.1016/j.jmoldx.2021.12.011 - DOI - PMC - PubMed

Publication types

LinkOut - more resources